ArticleGenome medicine2026
Attention-based deep learning for analysis of pathology images and gene expression data in lung squamous premalignant lesions.
Article in Genome medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
- Update of
Authors and funding
17 authors.
Funding
Abstract
backgroundMolecular and cellular alterations to the normal pseudostratified columnar bronchial epithelium results in the development of bronchial premalignant lesions representing a spectrum of histology from normal to hyperplasia, metaplasia, dysplasia (mild, moderate, and severe), carcinoma in situ and invasive carcinoma. Several studies have identified molecular alterations associated with lesion histology and progression. The broad and continuous spectrum of histologic and molecular changes makes reproducible stratification of lesions across multiple studies challenging.
methodsWe developed a transformer-based framework that flexibly utilizes transcriptomic and histologic patterns to distinguish lesions with bronchial dysplasia or worse from normal, hyperplasia, and metaplasia. We leveraged H&E whole slide images (WSIs) of endobronchial biopsies and bulk gene expression data (GE) derived from endobronchial biopsies and brushings from previously published studies and on-going lung precancer atlas efforts obtained from patients at high-risk for lung cancer.
resultsOn an external testing dataset of WSIs, the model trained on WSIs plus GE achieved an area under the ROC curve (AUROC) of 0.884 ± 0.040 compared to 0.829 ± 0.046 for the model trained on WSIs alone. On external testing datasets of GE, the model trained on WSIs plus GE achieved an AUROC of 0.857 ± 0.033 versus 0.713 ± 0.098 for a model trained on GE alone. Based on these results, we leveraged data across 4 studies to train a flexible fusion model that allows one or both data modalities (WSIs and GE) to be used in training. The model achieved an AUROC of 0.906 ± 0.034 on external testing WSIs data and 0.870 ± 0.023 on external testing GE data. Despite model training on a binary label, model probabilities were associated with histologic grade and the model identified gene expression alterations associated with bronchial dysplasia across multiple studies.
conclusionsOur multimodal transformer outperformed models trained on a single data modality and enabled the inclusion of samples with one or both modalities during training and/or testing. It increases the flexibility, scalability, and real-world applicability of disease severity assessment that better risk stratifies bronchial premalignant lesions even when only routine histology data is accessible.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.